These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 3286766

  • 1. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
    Heo DS, Whiteside TL, Kanbour A, Herberman RB.
    J Immunol; 1988 Jun 01; 140(11):4042-9. PubMed ID: 3286766
    [Abstract] [Full Text] [Related]

  • 2. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
    Wang YL, Si LS, Kanbour A, Herberman RB, Whiteside TL.
    Cancer Res; 1989 Nov 01; 49(21):5979-85. PubMed ID: 2507139
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
    Belldegrun A, Muul LM, Rosenberg SA.
    Cancer Res; 1988 Jan 01; 48(1):206-14. PubMed ID: 3257161
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL.
    J Immunol; 1989 Nov 15; 143(10):3404-11. PubMed ID: 2509557
    [Abstract] [Full Text] [Related]

  • 5. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS, Whiteside TL, Johnson JT, Chen KN, Barnes EL, Herberman RB.
    Cancer Res; 1987 Dec 01; 47(23):6353-62. PubMed ID: 3315186
    [Abstract] [Full Text] [Related]

  • 6. Tumor-specific cytolysis by lymphocytes infiltrating human melanomas.
    Topalian SL, Solomon D, Rosenberg SA.
    J Immunol; 1989 May 15; 142(10):3714-25. PubMed ID: 2785562
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K, Tilden AB, Balch CM.
    Cancer Res; 1986 Jun 15; 46(6):3011-7. PubMed ID: 3486040
    [Abstract] [Full Text] [Related]

  • 8. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
    Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS.
    Cancer Res; 1991 Aug 15; 51(16):4257-65. PubMed ID: 1868446
    [Abstract] [Full Text] [Related]

  • 11. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer.
    Peoples GE, Goedegebuure PS, Andrews JV, Schoof DD, Eberlein TJ.
    J Immunol; 1993 Nov 15; 151(10):5481-91. PubMed ID: 8228240
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells.
    Ioannides CG, Freedman RS, Platsoucas CD, Rashed S, Kim YP.
    J Immunol; 1991 Mar 01; 146(5):1700-7. PubMed ID: 1704404
    [Abstract] [Full Text] [Related]

  • 13. Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
    Whiteside TL, Heo DS, Takagi S, Herberman RB.
    Transplant Proc; 1988 Apr 01; 20(2):347-50. PubMed ID: 2834838
    [Abstract] [Full Text] [Related]

  • 14. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN, Dedoussis GV, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M.
    Cancer; 1994 Aug 15; 74(4):1275-82. PubMed ID: 7914469
    [Abstract] [Full Text] [Related]

  • 15. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S, Whiteside TL, Moretta L, von Fliedner V.
    J Immunol; 1987 Jun 01; 138(11):4004-11. PubMed ID: 3108380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. T-cell recognition of ovarian cancer.
    Peoples GE, Schoof DD, Andrews JV, Goedegebuure PS, Eberlein TJ.
    Surgery; 1993 Aug 01; 114(2):227-34. PubMed ID: 8342128
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH, Rayman P, Alexander J, Edinger M, Tubbs RR, Connelly R, Pontes E, Bukowski R.
    Cancer Res; 1990 Apr 15; 50(8):2363-70. PubMed ID: 2107973
    [Abstract] [Full Text] [Related]

  • 19. Solid-phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes.
    Massaro AF, Schoof DD, Rubinstein A, Zuber M, Leonard-Vidal FJ, Eberlein TJ.
    Cancer Res; 1990 May 01; 50(9):2587-92. PubMed ID: 2139356
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-2 expanded lymphocytes from lymph node and tumor biopsies of human renal cell carcinoma, breast and ovarian cancer.
    Bouet-Toussaint F, Genetel N, Rioux-Leclercq N, Bansard JY, Levêque J, Guillé F, Patard JJ, Lesimple T, Catros-Quemener V.
    Eur Cytokine Netw; 2000 Jun 01; 11(2):217-24. PubMed ID: 10903800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.